Valuation: Grifols, S.A.

Market Cap 5.69B 6.52B 5.37B 4.88B 9.14B 626B 9.18B 64.33B 24.83B 318B 24.5B 23.96B 1,024B P/E 2026 *
12.1x
P/E 2027 * 9.29x
Enterprise Value 14.13B 16.21B 13.34B 12.12B 22.7B 1,555B 22.8B 160B 61.69B 791B 60.88B 59.53B 2,544B EV / Sales 2026 *
1.85x
EV / Sales 2027 * 1.7x
Free-Float
79.65%
Yield 2026 *
2.86%
Yield 2027 * 3.16%
1 day-1.71%
1 week-2.85%
Current month-2.95%
1 month-2.19%
3 months+5.93%
6 months+4.24%
Current year-10.82%
1 week 9.47
Extreme 9.47
9.85
1 month 9.47
Extreme 9.47
10.17
Current year 8.43
Extreme 8.432
11.7
1 year 8.43
Extreme 8.432
12.87
3 years 6.36
Extreme 6.362
15.92
5 years 6.36
Extreme 6.362
22.64
10 years 6.36
Extreme 6.362
34.31
Manager TitleAgeSince
Chief Executive Officer 58 2024-03-31
Director of Finance/CFO 49 2024-09-15
Compliance Officer 54 2013-12-31
Director TitleAgeSince
Chairman 76 2010-01-24
Director/Board Member 70 2000-04-12
Director/Board Member 62 2015-05-23
Date Insider Type Main position Quantity % Market Cap. Importance
2/26/26 Free

Director

7,679 0.0018%
2/26/26 Free

Director

1,408 0.0005%
2/18/26 Others

Director

1,408 0.0003%
Change 5-day change 1-year change 3-year change Capi.($)
-1.71%-2.85%-19.85%-26.83% 6.63B
-0.58%+0.43%+31.09%-4.81% 78.83B
-2.55%+6.99%+505.27%+47.92% 63.11B
-1.11%+5.08%-11.47%-33.91% 60.48B
+0.14%-1.20%-11.64%+24.21% 46.75B
-0.24%+1.22%+2.26%+151.03% 45.66B
-1.62%-0.76%+49.85%-14.92% 32.37B
-1.81%+3.16%+45.71%+110.57% 25.87B
+0.47%+3.26%-0.77%+142.41% 21.33B
+0.27%+1.96%+62.19%+102.81% 15.8B
Average -0.87%+1.49%+65.26%+49.85% 39.68B
Weighted average by Cap. -0.94%+2.14%+92.82%+39.02%

Financials

2026 *2027 *
Net sales 7.65B 8.78B 7.23B 6.56B 12.3B 842B 12.35B 86.57B 33.41B 428B 32.97B 32.24B 1,378B 8.13B 9.33B 7.68B 6.97B 13.07B 895B 13.12B 91.99B 35.5B 455B 35.04B 34.26B 1,464B
Net income 536M 615M 506M 460M 861M 58.98B 865M 6.06B 2.34B 29.99B 2.31B 2.26B 96.48B 700M 803M 661M 600M 1.12B 77.01B 1.13B 7.92B 3.05B 39.15B 3.01B 2.95B 126B
Net Debt 8.45B 9.68B 7.97B 7.24B 13.57B 929B 13.62B 95.52B 36.86B 472B 36.38B 35.57B 1,520B 8.1B 9.29B 7.65B 6.95B 13.02B 892B 13.07B 91.66B 35.37B 453B 34.91B 34.14B 1,459B
Logo Grifols, S.A.
Grifols, S.A. specializes in the research, development, manufacturing and marketing of therapeutic products and medical devices for use in hospitals and medical analysis laboratories. Net sales break down by family of products and services as follows: - products derived from plasma (86.2%): products for use by the pharmaceutical and biotechnology industries; - diagnostic machines and reagents (8.5%): in vitro hemophilic diagnostic equipment, coagulation analyzers, infectious serology reagents, etc. for use primarily by blood banks and transfusion centers; - hospital products (2.1%): non-biological surgical products, radiology and nutritional products, etc. for use by hospital pharmacies; - other (3.2%): primarily intermediate biological products and subcontracted manufacturing services. Net sales are distributed geographically as follows: Spain (5.6%), European Union (15.9%), the United States and Canada (56.5%) and other (22%).
Employees
25,258
Date Price Change Volume
26-09-18 €9.542 -1.71% 1,648,892
26-09-17 €9.708 +1.55% 920,521
26-09-16 €9.560 -1.10% 1,343,542
26-09-15 €9.666 +0.02% 1,514,681
26-09-14 €9.664 -1.61% 1,499,985
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
12
Last Close Price
9.542EUR
Average target price
14.76EUR
Spread / Average Target
+54.67%

Quarterly revenue - Rate of surprise

LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!